Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report

Peer Review reports

Original Submission
3 Apr 2019	Submitted	Original manuscript
24 Apr 2019	Reviewed	Reviewer Report - Subramanyeswara Arekapudi
27 Apr 2019	Reviewed	Reviewer Report - Denis Dupoiron
27 May 2019	Author responded	Author comments - jing liu
Resubmission - Version 2
27 May 2019	Submitted	Manuscript version 2
6 Jun 2019	Reviewed	Reviewer Report - Subramanyeswara Arekapudi
17 Jun 2019	Reviewed	Reviewer Report - Denis Dupoiron
30 Jun 2019	Author responded	Author comments - jing liu
Resubmission - Version 3
30 Jun 2019	Submitted	Manuscript version 3
Publishing
9 Jul 2019	Editorially accepted
17 Jul 2019	Article published	10.1186/s12885-019-5915-7

Back to article page